Yeji
NDA/BLA filedconf 0.70

NDA/BLA filed

$NTLA · Intellia Therapeutics, Inc.
Event date
Date TBD
Sponsor runway
10 mo
$376.0M liquid

Evidence

Rolling biologics license application (BLA) submission initiated with the U.S. Food and Drug Administration (FDA); anticipate U.S. launch in the first half of 2027, if approved
Source: Press release · 2026-04-27View press release ↗

Comparable historical nda/bla fileds· last 5 years · same event type

TickerDrugDateOutcome
$AXSM2025-12-31unknown
$RCKTkresladi2025-10-14unknown
$ALDXreproxalap2025-07-17unknown
$ETONet-6002025-07-08unknown
$BCRXorladeyo (berotralstat)2025-05-14unknown
$CORTrelacorilant2025-03-03unknown
$ALDXreproxalap2024-11-01unknown
$AXSMaxs-072024-09-04unknown
$RCKTkresladi2023-10-02unknown
$GERNimetelstat2023-08-21unknown

Recent insider activity· ±90 days

No insider Form 4 activity reported on $NTLA in the 90 days around this event.